TP53 and neoplasm: However, this interaction are limited to late cases (stage III and IV) of patients treated adjuvant chemotherapy or neo adjuvant chemotherapy since strong signature of mitochondrial Phb1-p-p53 (ser15) interaction was not observed in naïve tumor sections or cancer cells not treated with CDDP.